Open AccessResponse of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C
Author(s) -
Javier Moreno,
Gloria Moraleda,
Rafael Bárcena,
Mluisa Mateos,
Santos del Campo
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i1.143
Subject(s) - ribavirin , viremia , medicine , virology , hepatitis c virus , virus , pegylated interferon , hepatitis c , immunology , gastroenterology
TT virus (TTV) is a newly described DNA virus related to postransfusion hepatitis that produces persistent viremia in the absence of clinical manifestations. PEG-IFN plus ribavirin have been useful in the treatment of chronic hepatitis C infection. This study investigated the responses of TT virus (TTV) and hepatitis C virus (HCV) to PEG-IFN plus ribavirin therapy.